Prosopis plant chemical composition and pharmacological attributes: Targeting clinical studies from preclinical evidence

Detalhes bibliográficos
Autor(a) principal: Sharifi-Rad, J
Data de Publicação: 2019
Outros Autores: Kobarfard, F, Ata, A, Ayatollahi, SA, Khosravi-Dehaghi, N, Jugran, AK, Tomas, M, Capanoglu, E, Matthews, KR, Popovic-Djordjevic, J, Kostic, A, Kamiloglu, S, Sharopov, F, Choudhary, MI, Martins, N
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://hdl.handle.net/10216/138978
Resumo: Members of the Prosopis genus are native to America, Africa and Asia, and have long been used in traditional medicine. The Prosopis species most commonly used for medicinal purposes are P. africana, P. alba, P. cineraria, P. farcta, P. glandulosa, P. juliflora, P. nigra, P. ruscifolia and P. spicigera, which are highly effective in asthma, birth/postpartum pains, callouses, conjunctivitis, diabetes, diarrhea, expectorant, fever, flu, lactation, liver infection, malaria, otitis, pains, pediculosis, rheumatism, scabies, skin inflammations, spasm, stomach ache, bladder and pancreas stone removal. Flour, syrup, and beverages from Prosopis pods have also been potentially used for foods and food supplement formulation in many regions of the world. In addition, various in vitro and in vivo studies have revealed interesting antiplasmodial, antipyretic, anti-inflammatory, antimicrobial, anticancer, antidiabetic and wound healing effects. The phytochemical composition of Prosopis plants, namely their content of C-glycosyl flavones (such as schaftoside, isoschaftoside, vicenin II, vitexin and isovitexin) has been increasingly correlated with the observed biological effects. Thus, given the literature reports, Prosopis plants have positive impact on the human diet and general health. In this sense, the present review provides an in-depth overview of the literature data regarding Prosopis plants’ chemical composition, pharmacological and food applications, covering from pre-clinical data to upcoming clinical studies.
id RCAP_cda1b760d57de4e3a9fbd22e4da713a0
oai_identifier_str oai:repositorio-aberto.up.pt:10216/138978
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Prosopis plant chemical composition and pharmacological attributes: Targeting clinical studies from preclinical evidenceMembers of the Prosopis genus are native to America, Africa and Asia, and have long been used in traditional medicine. The Prosopis species most commonly used for medicinal purposes are P. africana, P. alba, P. cineraria, P. farcta, P. glandulosa, P. juliflora, P. nigra, P. ruscifolia and P. spicigera, which are highly effective in asthma, birth/postpartum pains, callouses, conjunctivitis, diabetes, diarrhea, expectorant, fever, flu, lactation, liver infection, malaria, otitis, pains, pediculosis, rheumatism, scabies, skin inflammations, spasm, stomach ache, bladder and pancreas stone removal. Flour, syrup, and beverages from Prosopis pods have also been potentially used for foods and food supplement formulation in many regions of the world. In addition, various in vitro and in vivo studies have revealed interesting antiplasmodial, antipyretic, anti-inflammatory, antimicrobial, anticancer, antidiabetic and wound healing effects. The phytochemical composition of Prosopis plants, namely their content of C-glycosyl flavones (such as schaftoside, isoschaftoside, vicenin II, vitexin and isovitexin) has been increasingly correlated with the observed biological effects. Thus, given the literature reports, Prosopis plants have positive impact on the human diet and general health. In this sense, the present review provides an in-depth overview of the literature data regarding Prosopis plants’ chemical composition, pharmacological and food applications, covering from pre-clinical data to upcoming clinical studies.MDPI20192019-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10216/138978eng2218-273X10.3390/biom9120777Sharifi-Rad, JKobarfard, FAta, AAyatollahi, SAKhosravi-Dehaghi, NJugran, AKTomas, MCapanoglu, EMatthews, KRPopovic-Djordjevic, JKostic, AKamiloglu, SSharopov, FChoudhary, MIMartins, Ninfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-29T15:19:06Zoai:repositorio-aberto.up.pt:10216/138978Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:20:32.301630Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Prosopis plant chemical composition and pharmacological attributes: Targeting clinical studies from preclinical evidence
title Prosopis plant chemical composition and pharmacological attributes: Targeting clinical studies from preclinical evidence
spellingShingle Prosopis plant chemical composition and pharmacological attributes: Targeting clinical studies from preclinical evidence
Sharifi-Rad, J
title_short Prosopis plant chemical composition and pharmacological attributes: Targeting clinical studies from preclinical evidence
title_full Prosopis plant chemical composition and pharmacological attributes: Targeting clinical studies from preclinical evidence
title_fullStr Prosopis plant chemical composition and pharmacological attributes: Targeting clinical studies from preclinical evidence
title_full_unstemmed Prosopis plant chemical composition and pharmacological attributes: Targeting clinical studies from preclinical evidence
title_sort Prosopis plant chemical composition and pharmacological attributes: Targeting clinical studies from preclinical evidence
author Sharifi-Rad, J
author_facet Sharifi-Rad, J
Kobarfard, F
Ata, A
Ayatollahi, SA
Khosravi-Dehaghi, N
Jugran, AK
Tomas, M
Capanoglu, E
Matthews, KR
Popovic-Djordjevic, J
Kostic, A
Kamiloglu, S
Sharopov, F
Choudhary, MI
Martins, N
author_role author
author2 Kobarfard, F
Ata, A
Ayatollahi, SA
Khosravi-Dehaghi, N
Jugran, AK
Tomas, M
Capanoglu, E
Matthews, KR
Popovic-Djordjevic, J
Kostic, A
Kamiloglu, S
Sharopov, F
Choudhary, MI
Martins, N
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Sharifi-Rad, J
Kobarfard, F
Ata, A
Ayatollahi, SA
Khosravi-Dehaghi, N
Jugran, AK
Tomas, M
Capanoglu, E
Matthews, KR
Popovic-Djordjevic, J
Kostic, A
Kamiloglu, S
Sharopov, F
Choudhary, MI
Martins, N
description Members of the Prosopis genus are native to America, Africa and Asia, and have long been used in traditional medicine. The Prosopis species most commonly used for medicinal purposes are P. africana, P. alba, P. cineraria, P. farcta, P. glandulosa, P. juliflora, P. nigra, P. ruscifolia and P. spicigera, which are highly effective in asthma, birth/postpartum pains, callouses, conjunctivitis, diabetes, diarrhea, expectorant, fever, flu, lactation, liver infection, malaria, otitis, pains, pediculosis, rheumatism, scabies, skin inflammations, spasm, stomach ache, bladder and pancreas stone removal. Flour, syrup, and beverages from Prosopis pods have also been potentially used for foods and food supplement formulation in many regions of the world. In addition, various in vitro and in vivo studies have revealed interesting antiplasmodial, antipyretic, anti-inflammatory, antimicrobial, anticancer, antidiabetic and wound healing effects. The phytochemical composition of Prosopis plants, namely their content of C-glycosyl flavones (such as schaftoside, isoschaftoside, vicenin II, vitexin and isovitexin) has been increasingly correlated with the observed biological effects. Thus, given the literature reports, Prosopis plants have positive impact on the human diet and general health. In this sense, the present review provides an in-depth overview of the literature data regarding Prosopis plants’ chemical composition, pharmacological and food applications, covering from pre-clinical data to upcoming clinical studies.
publishDate 2019
dc.date.none.fl_str_mv 2019
2019-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/10216/138978
url https://hdl.handle.net/10216/138978
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2218-273X
10.3390/biom9120777
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136121960005633